Detalles de la búsqueda
1.
Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer.
Cell Mol Life Sci
; 80(11): 320, 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37815603
2.
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
J Transl Med
; 20(1): 556, 2022 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36463238
3.
Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways.
Int J Mol Sci
; 24(1)2022 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36614139
4.
Optical Fibre-Enabled Photoswitching for Localised Activation of an Anti-Cancer Therapeutic Drug.
Int J Mol Sci
; 22(19)2021 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34639185
5.
A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer.
Gynecol Oncol
; 159(3): 827-838, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32958271
6.
Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype.
Int J Mol Sci
; 22(1)2020 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33374698
7.
Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids.
Proteomics
; 19(21-22): e1900146, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474002
8.
S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Int J Mol Sci
; 19(12)2018 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572596
9.
Lymph node metastasis of primary endometrial cancers: Associated proteins revealed by MALDI imaging.
Proteomics
; 16(11-12): 1793-801, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27061135
10.
Novel IEF Peptide Fractionation Method Reveals a Detailed Profile of N-Terminal Acetylation in Chemotherapy-Responsive and -Resistant Ovarian Cancer Cells.
J Proteome Res
; 15(11): 4073-4081, 2016 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569743
11.
Erratum to "A first-in-class CDK4 inhibitor demonstrates in vitro, ex-vivo and in vivo efficacy against ovarian cancer" [Gynecologic Oncology 159 (2020) 827-838].
Gynecol Oncol
; 163(1): 215, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34340816
12.
MALDI Mass Spectrometry Imaging Reveals Decreased CK5 Levels in Vulvar Squamous Cell Carcinomas Compared to the Precursor Lesion Differentiated Vulvar Intraepithelial Neoplasia.
Int J Mol Sci
; 17(7)2016 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27399691
13.
Engineered CAR-T cells targeting the non-functional P2X purinoceptor 7 (P2X7) receptor as a novel treatment for ovarian cancer.
Clin Transl Immunology
; 13(5): e1512, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800555
14.
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.
BMC Cancer
; 13: 476, 2013 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24124770
15.
Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels.
Cancers (Basel)
; 15(18)2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760476
16.
Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 15(7)2023 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046833
17.
Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.
Int J Mol Sci
; 13(8): 9959-9970, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22949841
18.
Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations.
Cancers (Basel)
; 14(11)2022 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681748
19.
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
Int J Cancer
; 128(7): 1570-84, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20521251
20.
ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome.
Cancer Drug Resist
; 4(2): 485-502, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582032